Clinical trial
Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma
NCT00163748 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00163748 |
|---|---|
| Title | Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma |
| Official title | A Pilot Study of Outpatient Vinorelbine and Gemcitabine With Filgrastim Support for Patients With Relapsed or Refractory Lymphoma. |
| Lead sponsor | Bayside Health, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma, Hodgkin's Disease |
| Intervention type | Drug |
| Interventions | gemcitabine, vinorelbine |
| Enrollment | 40 |
| Start date | Feb 1, 2001 |
| Primary completion | Nov 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 8, 2016 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: